Edward Eunkee Whang, MD

Adjunct Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Whang, MD is a practicing Surgeon in Boston, MA. Dr. Whang graduated from University of Chicago Pritzker School of Medicine in 1991 and has been in practice for 28 years. He completed a residency at UCLA Medical Center. Dr. Whang is board certified in Surgery. Dr. Whang also practices at Boston Vamc in Jamaica Plain, MA.

Publications

  • Published 5/15/2025

    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Editor's Note: A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma Cells. Cancer Res. 2025 May 15; 85(10):1945. PMID: 40370067.

    Read at: PubMed

  • Published 5/15/2025

    Ito H, Duxbury M, Benoit E, Clancy TE, Zinner MJ, Ashley SW, Whang EE. Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2. Cancer Res. 2025 May 15; 85(10):1947. PMID: 40370066.

    Read at: PubMed

  • Published 5/15/2025

    Liau SS, Jazag A, Whang EE. Retraction: HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma. Cancer Res. 2025 May 15; 85(10):1946. PMID: 40370065.

    Read at: PubMed

  • Published 5/15/2025

    Liau SS, Whang E. Editor's Note: HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma. Clin Cancer Res. 2025 May 15; 31(10):2064. PMID: 40370047.

    Read at: PubMed

  • Published 5/15/2025

    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine Chemoresistance. Clin Cancer Res. 2025 May 15; 31(10):2065. PMID: 40370046.

    Read at: PubMed

Education

  • Pritzker School of Medicine, MD
  • Massachusetts Institute of Technology, BS